Imaging and clinical factors impacting PSA response in patients with metastatic castrate resistant prostate cancer undergoing Lu177-PSMA-617 therapy

被引：0
|
作者：
Boughdad, Sarah [1 ]
Meyer, Marie [1 ]
Da Mota, Michael [1 ]
Allenbach, Gilles [2 ]
Nicod-Lalonde, Marie [1 ]
Prior, John [3 ]
Schaefer, Niklaus [1 ]
机构：
[1] CHU Vaudois, Lausanne, Switzerland
[2] CHUV, Epalinges, Switzerland
[3] Lausanne Univ Hosp, La Conversion, Switzerland
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
80
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PSMA Expression Predicts Early Biochemical Response in Patients with Metastatic Castration-Resistant Prostate Cancer under 177Lu-PSMA-617 Radioligand Therapy
    Widjaja, Liam
    Werner, Rudolf A.
    Ross, Tobias L.
    Bengel, Frank M.
    Derlin, Thorsten
    CANCERS, 2021, 13 (12)
  • [42] Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
    Reyhaneh Manafi-Farid
    Sara Harsini
    Bahare Saidi
    Hojat Ahmadzadehfar
    Ken Herrmann
    Alberto Briganti
    Jochen Walz
    Mohsen Beheshti
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 4028 - 4041
  • [43] Response to 177 Lu-PSMA-617 radioligand therapy of liver metastases in patients with metastatic castrationresistant prostate cancer (mCRPC)
    Namazova, A.
    Sager, S.
    Sayman, H. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S673 - S673
  • [44] Therapeutic Responses and Survival Effects of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castrate-Resistant Prostate Cancer: A Meta-analysis
    Kim, Yong Joong
    Kim, Yong-il
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (10) : 728 - 734
  • [45] Circulating tumor cell molecular signatures of response to 177Lu-PSMA-617 therapy in metastatic prostate cancer patients
    Miyazawa, Yoshiyuki
    Konik, Arda
    Otani, Keisuke
    Pittie, Rea
    Rodden, Daniel
    Kelly, Justin
    Chung, Ella
    Ohtani, Yukako
    Badusi, Priscilla
    Pompa, Isabella
    Wan, Joshua
    Gao, Xin
    Kako, Bashar
    O'Shea, Aileen
    Heidari, Pedram
    Juric, Dejan
    Chevalier, Nicholas
    Miller, Miles
    Miyamoto, David
    Ng, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [46] Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
    Manafi-Farid, Reyhaneh
    Harsini, Sara
    Saidi, Bahare
    Ahmadzadehfar, Hojat
    Herrmann, Ken
    Briganti, Alberto
    Walz, Jochen
    Beheshti, Mohsen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (12) : 4028 - 4041
  • [47] Intermittent radioligand therapy with Lu-177-PSMA-617 in metastatic castration-resistant prostate cancer patients with favorable characteristics and early response
    Mader, N.
    Ngoc, C. Nguyen
    Baumgarten, J.
    Groener, D.
    Davis, K.
    Wichert, J.
    Tselis, N.
    Mandel, P.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S491 - S492
  • [48] Intermittent Lu-177-PSMA-617 therapy of metastatic castration-resistant prostate cancer in early responders
    Mader, Nicolai
    Ngoc, Christina Nguyen
    Baumgarten, Justus
    Groener, Daniel
    Davis, Karen
    Wichert, Jennifer
    Tselis, Nikolaos
    Mandel, Philipp
    Gruenwald, Frank
    Sabet, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [49] RESIST-PC phase 2 trial: 177Lu-PSMA-617 radionuclide therapy for metastatic castrate-resistant prostate cancer.
    Calais, Jeremie
    Fendler, Wolfgang P.
    Eiber, Matthias
    Lassmann, MIchael
    Dahlbom, Magnus
    Esfandiari, Rouzbeh
    Gartmann, Jeannine
    Nguyen, Kathleen
    Pan Thin
    Lok, Vincent
    Herrmann, Ken
    Czernin, Johannes
    Delpassand, Ebrahim
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Extended therapy with Lu-177-PSMA-617 in patients with high tumor load metastatic castration-resistant prostate cancer
    Mader, Nicolai
    Baumgarten, Justus
    Groner, Daniel
    Ngoc, Christina Nguyen
    Davis, Karen
    Banek, Severine
    Tselis, Nikolaos
    Happel, Christian
    Gruenwald, Frank
    Sabet, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345